Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

458 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.
Troya J, Ryan P, Ribera E, Podzamczer D, Hontañón V, Terrón JA, Boix V, Moreno S, Barrufet P, Castaño M, Carrero A, Galindo MJ, Suárez-Lozano I, Knobel H, Raffo M, Solís J, Yllescas M, Esteban H, González-García J, Berenguer J, Imaz A; GESIDA-8314 Study Group. Troya J, et al. Among authors: solis j. PLoS One. 2016 Oct 11;11(10):e0164455. doi: 10.1371/journal.pone.0164455. eCollection 2016. PLoS One. 2016. PMID: 27727331 Free PMC article.
Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study.
Troya J, Montejano R, Ryan P, Gómez C, Matarranz M, Cabello A, Vera F, Sepúlveda MA, Santos I, Samperiz G, Bachiller P, Boix V, Barrufet P, Cervero M, Sanz J, Solís J, Yllescas M, Valencia E; GESIDA-8715 Study Group. Troya J, et al. Among authors: solis j. PLoS One. 2018 Jun 14;13(6):e0198768. doi: 10.1371/journal.pone.0198768. eCollection 2018. PLoS One. 2018. PMID: 29902204 Free PMC article.
Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.
Troya J, Ryan P, Ribera E, Podzamczer D, Hontañón V, Terrón JA, Boix V, Moreno S, Barrufet P, Castaño M, Carrero A, Galindo MJ, Suárez-Lozano I, Knobel H, Raffo M, Solís J, Yllescas M, Esteban H, González-García J, Berenguer J, Imaz A; GESIDA-8314 Study Group. Troya J, et al. Among authors: solis j. PLoS One. 2017 Feb 9;12(2):e0172184. doi: 10.1371/journal.pone.0172184. eCollection 2017. PLoS One. 2017. PMID: 28182783 Free PMC article.
[Chylothorax as presenting form of a gastric adenocarcinoma].
Martín-Joven A, Fernández Ballesteros A, Cervero M, Marco J, Solís J. Martín-Joven A, et al. Among authors: solis j. Rev Esp Enferm Dig. 1996 Dec;88(12):880-1. Rev Esp Enferm Dig. 1996. PMID: 9072060 Spanish.
[Analysis of hospital admittance and mortality in AIDS patients].
Cervero M, Jusdado JJ, Torres R, Solís J. Cervero M, et al. Among authors: solis j. Enferm Infecc Microbiol Clin. 2004 Aug-Sep;22(7):436; author reply 436-8. doi: 10.1016/s0213-005x(04)73131-6. Enferm Infecc Microbiol Clin. 2004. PMID: 15355778 Spanish. No abstract available.
Prostatic and renal aspergillosis in a patient with AIDS.
Cervero M, Marco J, Fernandez-Ballesteros A, Plaza S, Agud JL, Solis J. Cervero M, et al. Among authors: solis j. Am J Med. 1999 Jan;106(1):123. Am J Med. 1999. PMID: 10320130 No abstract available.
[Chylothorax and hepatic cirrhosis].
Cervero M, Marco J, Yoldi M, Agud JL, Solís J. Cervero M, et al. Among authors: solis j. Rev Esp Enferm Dig. 1998 Apr;90(4):310-1. Rev Esp Enferm Dig. 1998. PMID: 9623276 Spanish. No abstract available.
458 results